Dynavax Technologies Corp

+$0.18 (+1.6%)
Closing Price on June 21, 2024

DVAX Chart and Intraday Price

DVAX Company Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 1,666.65M USD
Shares Outstanding 130,615,000
Dynavax Technologies Corp is a biopharmaceutical company based in Emeryville, California, specializing in the development and commercialization of vaccines. Its flagship product is HEPLISAV-B, a hepatitis B vaccine designed for adults, which is available in the United States and Europe. The company also produces CpG 1018, a key ingredient in HEPLISAV-B. Dynavax collaborates with several global partners to expand its vaccine offerings and improve public health outcomes.

DVAX Articles

Wednesday's top analyst upgrades and downgrades included Altice USA, Boeing, Dynavax, EnLink Midstream, FedEx, Hasbro, Meta Platforms, Micron Technology, Snap and TransDigm.
Friday's top analyst upgrades and downgrades included CenterPoint Energy, Cloudflare, Dynavax Technologies, HCA Healthcare, Opendoor Technologies, Roku, Salesforce.com, Spotify Technology and Wheaton...
Tuesday afternoon's top analyst upgrades and downgrades included Amazon.com, Darden Restaurants, Deere, Lam Research, Oracle, Palo Alto Networks and Zoom Video Communications.
Friday’s top analyst upgrades and downgrades included BP, Cloudflare, Expedia, FireEye, Marathon Oil, Moderna, Pinduoduo, Vertex Pharmaceuticals and ViacomCBS.
24/7 Wall St. has compiled a list of some speculative biotech plays that could see gains of up to 300% in the coming months.
Friday's top analyst upgrades and downgrades included Alteryx, Booking, CarGurus, Datadog, FedEx, First Solar, Uber Technologies, Vonage, Yeti and Zillow.
Dynavax Technologies shares made a handy gain on Thursday after the company announced that it would be entering the coronavirus vaccine business. Is the market for these vaccines getting...
The top analyst upgrades, downgrades and other research calls from Thursday include Andeavor, Cimarex Energy, Groupon, Macy's, Marathon Petroleum, Match Group and Republic Services.
Dynavax Technologies saw its shares make a handy gain early on Wednesday after the company announced that it received a recommendation from the CDC's Advisory Committee on Immunization Practices.
The top analyst upgrades, downgrades and other research calls from Monday include Apple, BHP Billiton, CBS, Eli Lilly, GE, Halliburton, IBM, Schlumberger and Verizon.
A new RBC report is reasonably positive on the biotech sector for the coming year. These eight top picks for 2018 all have the potential for big upside moves.
These are some of the biggest biopharma stocks moving on Wednesday, as markets have hit new intraday highs, continuing to climb in the wake of the White House announcements.
24/7 Wall St. has collected several catalysts that are coming up on the calendar in the month of December.
Now that the U.S. presidential election is over and markets have recovered to their highs, there are still some stocks holding back the markets from breaking even higher.
November 14, 2016: Here are four stocks trading with relatively heavy volume among 75 equities making new 52-week lows in Monday’s session. On the NYSE, advancers led decliners by less than 100...